Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

Total article views   HTML views PDF downloads Totals
15,304 Dovepress* 15,304+ 3,436 18,740
Totals 15,304 3,436 18,740
*Since 12 April 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 0 6

View citations on Google Scholar